Literature DB >> 22674222

Hematologic malignancies: an opportunity to fill a gap in cancer surveillance.

Lynne Penberthy1, Donna McClish, Steven Peace, Laurel Gray, Jim Martin, Sandra Overton, Soundarya Radhakrishnan, Chris Gillam, Gordon Ginder.   

Abstract

BACKGROUND: Reporting of hematologic malignancies is an increasingly important focus for cancer surveillance. As trends in cancer care are shifting to the outpatient setting, hospital-based data collection methods used for cancer surveillance will result in under-reporting of these cancers. This study describes the testing and validation of an automated system for capturing and reporting cancers from community oncology providers.
METHODS: The system was evaluated in 5 oncology practices in two states processing claims data for a 4- or 8-month interval. Resulting cancers were matched with the state registries. A random sample of nonmatched cases was reabstracted to measure the accuracy of the claims data for reporting of hematologic malignancies.
RESULTS: The overall match rate for the 1,935 hematologic malignancies reported during the study period was 58.2 % (range, 37.4 % for CLL to 71.2 % for Hodgkin's Lymphoma). The overall accuracy rate for billing-reported hematologic malignancies was 95 %. Accuracy among cases that did not match with the cancer registry was 88 %. The estimated number of missed cases for the five participating practices ranged from 0.8 leukemia cases/oncologist/year to 3.4 CLL cases/oncologist/year. The estimated total number of missed cases in the five participating practices was 292 with an interquartile range of 263-323.
CONCLUSION: As cancer diagnosis and treatment continue migration into ambulatory physician practice settings unreported hematopoietic cases will become increasingly problematic. Leveraging the standardized electronic billing data for automated reporting of cancer cases from physician practices may be an efficient method to reduce this gap in cancer surveillance reporting.

Entities:  

Mesh:

Year:  2012        PMID: 22674222     DOI: 10.1007/s10552-012-0003-1

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  2 in total

1.  Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.

Authors:  Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-15       Impact factor: 4.254

2.  Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries.

Authors:  Clara J K Lam; Joan L Warren; Matthew Nielsen; Angela Smith; Eric Boyd; Michael J Barrett; Angela B Mariotto
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.